Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Other Non-Current Liabilities (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Other Non-Current Liabilities for 8 consecutive years, with $79.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities rose 9.34% to $79.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $79.9 million, a 9.34% increase, with the full-year FY2025 number at $79.9 million, up 9.34% from a year prior.
  • Other Non-Current Liabilities was $79.9 million for Q4 2025 at Select Medical Holdings, up from $76.0 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $172.7 million in Q2 2021 to a low of $73.0 million in Q4 2024.
  • A 5-year average of $106.0 million and a median of $105.1 million in 2022 define the central range for Other Non-Current Liabilities.
  • Peak YoY movement for Other Non-Current Liabilities: skyrocketed 62.65% in 2021, then plummeted 37.74% in 2022.
  • Select Medical Holdings' Other Non-Current Liabilities stood at $106.4 million in 2021, then dropped by 0.29% to $106.1 million in 2022, then fell by 22.01% to $82.8 million in 2023, then decreased by 11.77% to $73.0 million in 2024, then rose by 9.34% to $79.9 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Other Non-Current Liabilities are $79.9 million (Q4 2025), $76.0 million (Q3 2025), and $73.3 million (Q2 2025).